Publication Name	World Journal of Gastroenterology
Manuscript ID	6753
Country	Greece

Received	2013-10-28 13:37
Peer-Review Started	2013-10-28 20:04
To Make the First Decision	2013-11-13 15:43
Return for Revision	2013-11-20 16:17
Revised	2013-12-18 01:50
Second Decision	2014-04-16 11:12
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-04-16 12:22
Articles in Press	2014-05-23 10:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-27 15:06
Publish the Manuscript Online	2014-07-14 17:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Topic Highlights
Article Title	Nonalcoholic fatty liver disease and polycystic ovary syndrome
Manuscript Source	Invited Manuscript
All Author List	Evangeline Vassilatou
Funding Agency and Grant Number
Corresponding Author	Evangeline Vassilatou, MD, PhD, Endocrine Unit, 2nd Department of Internal Medicine - Propaedeutic, “Attikon” University Hospital, 1 Rimini st., 12462 Athens, Greece. niadas@hol.gr
Key Words	Nonalcoholic fatty liver disease; Polycystic ovary syndrome; Insulin resistance; Obesity; Hyperandrogenism; Premenopausal women
Core Tip	Nonalcoholic fatty liver disease (NAFLD) is frequent in patients with polycystic ovary syndrome (PCOS). Obesity and insulin resistance are considered as the main factors related to NAFLD in PCOS. Androgen excess may be an additional contributing factor to the development of NAFLD. Limited data imply that advanced stage of liver disease is possibly more frequent in obese PCOS patients with NAFLD. PCOS patients, particularly obese patients with the metabolic syndrome, should be screened for NAFLD. Long-term follow up studies are needed to clarify clinical implications, appropriate diagnostic evaluation and optimal treatment for PCOS patients with NAFLD.
Publish Date	2014-07-14 17:39
Citation	Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol 2014; 20(26): 8351-8363
URL	http://www.wjgnet.com/1007-9327/full/v20/i26/8351.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i26.8351

Full Article (PDF)	WJG-20-8351.pdf
Full Article (Word)	WJG-20-8351.doc
Manuscript File	6753-Review.docx
Answering Reviewers	6753-Answering reviewers.pdf
Copyright License Agreement	6753-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6753-Language certificate.pdf
Peer-review Report	6753-Peer reviewer(s).pdf
Scientific Editor Work List	6753-Scientific editor work list.doc